Propentofylline, a Glial Modulating Agent, Exhibits Antiallodynic Properties in a Rat Model of Neuropathic Pain
- 1 June 2001
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 297 (3) , 1210-1217
- https://doi.org/10.1016/s0022-3565(24)29652-x
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cellsEuropean Journal of Immunology, 1999
- The Effect of Site and Type of Nerve Injury on Spinal Glial Activation and Neuropathic Pain BehaviorExperimental Neurology, 1999
- Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behaviorGlia, 1998
- Adenosine and Propentofylline Inhibit the Proliferation of Cultured Microglial CellsExperimental Neurology, 1996
- Tumor necrosis factor‐α induces substance P in sympathetic ganglia through sequential induction of interleukin‐1 and leukemia inhibitory factorJournal of Neurobiology, 1995
- Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculationBiochemical Pharmacology, 1994
- Inhibitory effects of propentofylline on [3H]adenosine influxBiochemical Pharmacology, 1993
- An adenosine uptake blocker, propentofylline, reduces glutamate release in gerbil hippocampus following transient forebrain ischemiaNeurochemical Research, 1992
- Stimulation of nerve growth factor synthesis/secretion by propentofylline in cultured mouse astroglial cellsBiochemical Pharmacology, 1990
- Displacement of synaptic terminals from regenerating motoneurons by microglial cellsCell and tissue research, 1968